| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | -69.8% |
| R&D Expense | $19.3M | — | -23.2% |
| SG&A Expense | $6.5M | — | -4.0% |
| Operating Income | -$24.6M | — | +11.6% |
| Pre-tax Income | -$23.0M | — | +7.6% |
| Income Tax | $10K | — | -89.8% |
| Net Income | -$23.1M | — | +7.9% |
| EPS (Basic) | -$0.61 | — | +10.3% |
| EPS (Diluted) | -$0.61 | — | +10.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.3M | -39.3% | -13.3% |
| Accounts Receivable | $0 | -100.0% | -100.0% |
| Current Assets | $144.6M | -12.7% | -38.0% |
| Total Assets | $197.0M | -10.9% | -33.9% |
| Current Liabilities | $22.5M | -1.9% | -43.6% |
| Total Liabilities | $59.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.2M | — | +7.3% |
| Capital Expenditures | $25K | — | -91.3% |
| Investing Cash Flow | $4.0M | — | -83.9% |
| Financing Cash Flow | -$27K | — | +64.9% |
| Free Cash Flow | -$21.2M | — | +8.3% |
| -30.6% |
| Stockholders' Equity | $137.8M | -13.1% | -35.2% |